Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 210 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review

Haikal Ammar, Borba E, Khaja Taqui, Doolittle Gary, Schmidt Paul

Year : 2018| Volume: 8| Issue : 1 | Page no: 34-36

   This article has been cited by
1 An update on the safety of nivolumab for the treatment of advanced melanoma
Anna M Czarnecka,Piotr Rutkowski
Expert Opinion on Drug Safety. 2020; 19(4): 409
[Pubmed]  [Google Scholar] [DOI]
2 Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment
Susan Morand,Hannah Staats,Justin Fortune Creeden,Azwar Iqbal,Bashar Kahaleh,Laura Stanbery,Lance Dworkin,John Nemunaitis
Future Oncology. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Management of immune checkpoint inhibitor-related adverse events: A review of case reports
Xiaoyan Si,Peng Song,Jun Ni,Mingyi Di,Chunxia He,Li Zhang,Xiaowei Liu,Yue Li,Hanping Wang,Xiaoxiao Guo,Jiaxin Zhou,Lian Duan,Xu Yang,Mengzhao Wang,Li Zhang
Thoracic Cancer. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature
Bicky Thapa,Asad Ali,Raunak Nair,Rishik Vashisht,Cassandra Calabrese
Case Reports in Rheumatology. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
5 Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma
Masataka Nishikawa,Atsushi Goshima,Hajime Owaki,Takeshi Fuji
Clinical Drug Investigation. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article